A novel human IgA monoclonal antibody protects against tuberculosis. - Wikidata - wikimedia - TriplyDB

A novel human IgA monoclonal antibody protects against tuberculosis.

A novel human IgA monoclonal antibody protects against tuberculosis.

http://www.wikidata.org/entity/Q33800841

about

Immunotherapy for tuberculosis: future prospects Antibodies and tuberculosis Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.The human antibody response to the surface of Mycobacterium tuberculosis.The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19).Histopathological Study of the Lungs of Mice Receiving Human Secretory IgA and Challenged with Mycobacterium tuberculosis The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Long-lived memory B-cell responses following BCG vaccination.Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Principles and application of antibody libraries for infectious diseases.Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.Functional flexibility of intestinal IgA - broadening the fine line.Cellular and humoral mechanisms involved in the control of tuberculosis Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.B cells and antibodies in the defense against Mycobacterium tuberculosis infection Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells.Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8.Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.Antibody-mediated immunity against tuberculosis: implications for vaccine development Vaccination sequence effects on immunological response and tissue bacterial burden in paratuberculosis infection in a rabbit model.Immunoglobulin A: A next generation of therapeutic antibodies?Structure and function relationships in IgA.Bovine paratuberculosis: recent advances in vaccine development.Fc-fusion proteins: new developments and future perspectives.An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.Function and Potentials of M. tuberculosis Epitopes Development of a new tuberculosis vaccine: is there value in the mucosal approach?Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.B lymphocytes that migrate to tuberculous pleural fluid via the SDF-1/CXCR4 axis actively respond to antigens specific for Mycobacterium tuberculosis.Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis.A Functional Role for Antibodies in Tuberculosis.Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen.Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis.Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation Cellular Architecture of Spinal Granulomas and the Immunological Response in Tuberculosis Patients Coinfected with HIV.Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy.

P2860

Q26741261-A10F9FE5-EAB8-4827-A0BE-75DAF169FBB0 Q28067735-98B44AF0-1701-4E6F-8101-26FB85BB40EA Q33719289-CC7F169D-9C4D-4D5A-A139-82747CBEF75A Q33740190-AEEB98AD-04BC-444C-99A1-675665112E66 Q33968915-6D5A34C7-A861-49B5-B2E6-28A3918218D6 Q34178105-753ADDE4-294F-4403-8A71-BB1D9B3D5608 Q34218284-DB7D4D93-FD87-4EA2-9283-98390F4B45F2 Q34499286-2A97C1B0-C8FB-4480-9FF1-24F0287D4C13 Q34512334-44618FA3-3C1F-4DF4-B517-D91667AA5194 Q35164284-EC47FF32-5FEE-42C8-A926-AEA04D42B544 Q35249355-A5ADB7D8-4BC9-4F9B-A3AE-09F01C336CBD Q35312084-E3F8EE21-3DA5-4ED3-A99B-6D80D42E4288 Q35929062-F4F1B7BC-5455-4FC9-9AD3-0A6080C19301 Q35996521-D508D9F0-227C-4B57-8909-49F454B0F810 Q36216363-DE47CB0B-BA9D-4F89-B6A5-533CBE14D4C4 Q36237421-7D31706C-845C-46F2-8249-30E5C0005B7C Q36238031-EA036B42-CCD9-40C1-A0B4-7CA3810DE7EA Q36366594-E6A7AAB3-A01A-4C7F-8004-EFA5D5B8CB0C Q36487349-94D111C7-410D-42D5-9096-DA5B536E27DC Q36500269-A650F64D-F5E4-4C62-979A-49F9CDE10DD5 Q36927153-B714EC86-5452-4F62-95DB-CACC71C213F7 Q37137882-C7B5CE7E-6737-4B11-8ADA-1776AE3FBB30 Q37156509-5E39E85A-5955-4E97-87A9-CDFAD0D58A79 Q37892323-CB6A3BA8-1A98-4206-9AAB-B91C8810C2FD Q37936765-E6958442-12A2-4BE4-9B92-270C834B57CA Q37955274-51102E14-6E73-459A-9DA9-2DCB5677C2B3 Q38029985-839D5BDF-7450-48A5-BA37-2744EA7BDC61 Q38041566-0FA11184-26C0-4221-ACD6-795C34325B1D Q38203257-7559A044-B512-468B-9B97-33877F9A0358 Q38262258-31BBB88C-7D54-4801-9D4E-1A77523D00EC Q38620366-2FD28D57-7A32-4408-AC34-9F977B9C3674 Q39002020-2A3953A1-AA76-49D0-9972-5724F6BE2CD7 Q39197564-8CD66BA9-2F01-4522-A5A3-F86A63E0B477 Q39301694-83BBF7C8-1425-4D39-A873-FF93EFB36558 Q39352413-3A967B66-BEB0-4486-A11F-8A890E31CEF5 Q39961868-3293A7CC-984C-4002-898A-A78022FA05DB Q40086314-D671F072-F060-44E4-B416-94DBCE38E80A Q40868823-B0F7E817-C27A-4AD8-BA3E-E07AE57D8669 Q41684142-E2F6E5AF-154C-4E91-8B2B-8E1BA5D76945 Q41704272-8CBB4A20-6C7B-4BEB-A9F6-D6F542C17A04

P2860

A novel human IgA monoclonal antibody protects against tuberculosis.

http://www.wikidata.org/entity/Q33800841

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A novel human IgA monoclonal antibody protects against tuberculosis.

@ast

A novel human IgA monoclonal antibody protects against tuberculosis.

@en

type

label

A novel human IgA monoclonal antibody protects against tuberculosis.

@ast

A novel human IgA monoclonal antibody protects against tuberculosis.

@en

prefLabel

A novel human IgA monoclonal antibody protects against tuberculosis.

@ast

A novel human IgA monoclonal antibody protects against tuberculosis.

@en

P1433

Q33800841-D6E05B94-C1D1-4319-816B-FA678E2E7E5D

P1476

Q33800841-396CC563-BDD7-45E7-89D5-6E6868FA2344

P2093

Q33800841-47B9E628-9F41-47DD-9784-EB9D60F2F21B

Q33800841-65BF90C9-E1EB-4768-9965-CAC4F0322EE9

Q33800841-917E0A3E-FE45-4F2E-923A-B7157809B966

Q33800841-958582CF-EF39-4AC2-8201-ACE6F812380E

Q33800841-ADF6DDDC-4D92-4CFF-A313-E9F6552A6B5A

Q33800841-B42D5116-6CCC-4F5D-83D8-1127D83F6B40

Q33800841-EBB90C97-2B45-4C96-8D3C-614887FB8400

P2860

Q33800841-07460F87-05CA-48ED-807A-A73CFE0A8801

Q33800841-0ADCBCAB-18C5-4072-BC25-044046DF59CC

Q33800841-0FBDDB0E-1F2E-415C-A159-F5ADCD7BEF26

Q33800841-20713639-0147-4D11-9129-162A7D0FFF04

Q33800841-20CB2D21-9FD6-4301-8B56-CD13B8319306

Q33800841-233EE8AF-EE2D-4C56-A768-0EE66E4DC635

Q33800841-4A9DA8F5-674F-4822-9EFC-D76F4AD04AC6

Q33800841-4F072D7E-4B3F-4F8B-97D3-BA7640DE5D4C

Q33800841-5D85E40B-250B-48F4-8475-35C9FB7359B0

Q33800841-5DAFD704-F458-4964-8552-05C3E5F0FC57

P304

Q33800841-797FA96B-5B18-4D8B-9FD4-AFE2BFD60195

P31

Q33800841-756E9869-F6F8-4CD2-8468-A4EB39866B98

P356

Q33800841-6DC6DF32-6F32-4830-91B0-26EECFD0911B

P407

Q33800841-81A9643A-A832-4FD7-9CD1-F900DF08F5BD

P433

Q33800841-791916B8-42E6-40F0-B897-B1D90938DCFA

P478

Q33800841-5479A221-06E6-474E-860E-39423F670D7C

P50

Q33800841-0D2E28E3-DBEB-43C9-B882-8D85E02C67A3

Q33800841-3FF85406-4621-4AEC-8F17-AF9C445B14E5

Q33800841-4C05D371-9B2E-44E9-8D62-AAE0F9F7E379

P577

Q33800841-423E2702-D429-47F3-A88F-0A0F9B362E8B

P5875

Q33800841-B42D25AB-4D21-4077-8174-A812D347F0D9

P698

Q33800841-32CB3787-664F-4F14-82B1-0506669D334A

P921

Q33800841-690AAA4D-E624-400E-A11D-1C593045C9C3

Q33800841-6B41B669-8DDF-4677-B8A2-C3896CEA1F1D

P932

Q33800841-EBD97669-11ED-4E0F-9B25-DD8E341D4304

P356

JIMMUNOL.1003189

P1433

Journal of Immunology

P1476

A novel human IgA monoclonal antibody protects against tuberculosis.

@en

P2093

Cees van Kooten

http://www.w3.org/2001/XMLSchema#string

Jenny M Woof

http://www.w3.org/2001/XMLSchema#string

Juraj Ivanyi

http://www.w3.org/2001/XMLSchema#string

Melanie J Lewis

http://www.w3.org/2001/XMLSchema#string

Rajko Reljic

http://www.w3.org/2001/XMLSchema#string

Richard McIntosh

http://www.w3.org/2001/XMLSchema#string

Sucharitha Balu

http://www.w3.org/2001/XMLSchema#string

P2860

Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary

Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89

The Fc receptor for IgA (FcalphaRI, CD89)

Antibody arrays for high-throughput screening of antibody-antigen interactions.

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice

Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.

Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Tuberculosis control in the era of HIV.

P304

3113-3119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1003189

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P50

Marjolein van Egmond

Richard J. Pleass

Stephen Challacombe

P577

2011-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49777186

http://www.w3.org/2001/XMLSchema#string

P698

21257971

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3115510

http://www.w3.org/2001/XMLSchema#string